Advertisement
However, Bharat Biotech recently announced that it will start the trials of its indigenous Covaxin on children and youngsters in the age group of 2-18 years by February-end or early March
It is said that the tests will be conducted for children in the age group of 2-5 years, 6 to 12 years and 12-18 years. Also a special protocol will be maintained for such trials.
The trials will take place at a leading children’s hospital in Nagpur once Bharat Biotech receives approval from the government
Related Articles
Advertisement
Covaxin of Bharat Biotech and Covishield of Oxford University-AstraZeneca are approved in India but only Covaxin is developed from inactivated virus.
The inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) biocontainment facility, one of its kind in the world.